problems with digital currency Reviews

Market News: It is reported that Iraq's strategic wheat reserve is enough to meet the consumption for more than six months.Zhuhai Guanyu: It was selected as the designated supplier of low-voltage lithium batteries for its 12V cars after being notified by domestic car companies. Zhuhai Guanyu announced that the company was recently notified by a domestic car company and was selected as the designated supplier of low-voltage lithium batteries for its 12V cars. This appointment will help to enhance the company's competitiveness and sustainable development ability in this field, and lay the foundation for future market share enhancement. At present, the company has been recognized by many well-known car companies, such as SAIC, Zhiji, Jaguar Land Rover, Stellantis, GM, etc., and has obtained a number of vehicle project designation letters. However, the fixed-point notice is not the final supply agreement, and the project needs to go through many links from fixed-point to mass production, so it is uncertain whether the order can be obtained in the end.Zhuhai Guanyu: It has been notified by domestic car companies. Zhuhai Guanyu announced that the company has recently been notified by a domestic car company to select the company as its designated supplier to develop and supply low-voltage lithium batteries for 12V cars.

Bei Ya raised Broadcom's target price from $195.00 to $210.00.Macron rejected our proposal and appointed one of his allies as Prime Minister. We will not enter the government, and Macron chooses to continue his policy.Shanghai launched a new special campaign and issued coupons again! The civilized market and supporting promotion in Wujiaochang business district lasted for 10 days. On December 13th, the special action of "Going to the Covenant of Civilizations" by civilized units in Shanghai to help the joint development of cultural and sports tourism and business exhibitions was launched. The first stop was opened in Wujiaochang, Yangpu District, and it was divided into three sections: civilized market, flash stage and supporting promotion, which will last for 10 days. After mobilization and negotiation, merchants and enterprises in Wujiaochang Business Circle, Daxue Road and Guohua Plaza jointly launched a number of exclusive coupons for "Going to the Covenant of Civilization" during the event, including more than 30,000 limited coupons and 18 unlimited coupons, covering restaurants, food, beauty and clothing, and fashionable life businesses, which not only brought tangible benefits to the citizens, but also helped the business circle to drain and develop the real economy. The citizens can check the H5 activity page through the "Shanghai Yangpu" WeChat WeChat official account, and grab coupons and write them off at 10:00 every day from December 13th to 22nd. (Watch the news)

Huabei Pharmaceutical Co., Ltd.: Four kinds of drugs under the company are planned to be selected for national centralized drug procurement. Huabei Pharmaceutical announced that the company and its subsidiary Xiantai Company participated in the tenth batch of national centralized drug procurement, and all four varieties are planned to be selected, including penicillin sodium for injection, piperacillin sodium for injection, ampicillin sodium for injection and sulbactam sodium for injection. The price of the drug to be selected this time has decreased compared with the original sales price. In 2023, the sales income of penicillin sodium for injection was 129 million yuan, accounting for 1.28% of the annual operating income. If the bid is confirmed and the purchase and sale contract is signed, the company will fully guarantee the supply according to the demand of the selected area, and promote the increment of related products in the selected area and the development of the off-standard market.The self-built valuation model of bank wealth managers has met with "standardization": some institutions have re-adopted the strategy of excess return of the bank's tier-2 capital bonds with the valuation system of China Securities and China Securities, and recently, the regulatory authorities issued a document to the bank wealth management subsidiary, demanding that the self-built valuation model should not be used to smooth the net value fluctuation, and the valuation standards provided by third parties such as China Securities and China Securities should be adopted, and self-inspection and rectification should be carried out. The purpose of this move is to prevent the bank's wealth management subsidiaries from adjusting product income through self-built models, and to carry out "fund pool" business in disguise to ensure market fairness. At present, a number of bank wealth management subsidiaries have received this document, and have begun to adjust the net value calculation methods of day-opening and closed wealth management products, and re-adopt third-party valuation for investment products such as bank tier 2 capital bonds. A person from a bank financing subsidiary told reporters that he heard that the financial supervision department held a small-scale meeting last week, asking the bank financing subsidiary to respect the new asset management rules and not to violate accounting standards. In addition, the relevant departments also require the financial subsidiaries of banks that have used the self-built valuation model to carry out rectification, and the financial subsidiaries that have been notified shall submit corresponding rectification plans and measures reports within one month. In the view of the above-mentioned bank wealth managers, it is not excluded that some bank wealth management subsidiaries have lowered the allocation ratio of bank tier-2 capital bonds due to the influence of regulatory policies, because when the self-built valuation model is "standardized", the strategy of over-allocating bank tier-2 capital bonds to obtain excess returns becomes increasingly difficult when the net product value fluctuates relatively smoothly. (per meridian)Kexing launched the world's first phase III clinical study of bivalent inactivated enterovirus vaccine. On December 13th, the first volunteer was enrolled in the phase III clinical study of bivalent inactivated enterovirus vaccine developed by Beijing Kexing Biological Products Co., Ltd., a subsidiary of Kexing Holding Biotechnology Co., Ltd. (hereinafter referred to as "Kexing"). The vaccine is used to prevent hand, foot and mouth disease caused by enterovirus 71 (EV71) and coxsackie virus 16 (CA16). A multicenter, randomized, double-blind, controlled study design was adopted in this phase III clinical study to evaluate the protective efficacy, safety and immunogenicity of the vaccine in children aged 6-71 months.